Literature DB >> 18369814

hTERT knockdown in human embryonic kidney cells using double-stranded RNA.

Serene R Lai1, Lucy G Andrews, Trygve O Tollefsbol.   

Abstract

The method of RNA interference (RNAi) is an easy means of knocking down a gene without having to generate knockout mutants, which may prove to be difficult and time consuming. RNAi is a naturally occurring process that involves targeting the mRNA of a gene by introducing RNAs that are complementary to the target mRNA. The foreign RNAs activate an endogenous enzyme, DICER, which degrades the target mRNA. There are many ways of eliciting the RNAi response in a cell. In this chapter, we describe the use of double-stranded RNA (dsRNA) to knockdown human telomerase reverse transcriptase (hTERT), the gene that codes for the catalytic subunit of the human telomerase enzyme. dsRNA can be used to generate the RNAi response in cells of embryonic origin, such as human embryonic kidney (HEK) cells. The RNAi effect is transient because the dsRNA eventually gets degraded in the cells, and it is useful to study the short-term effects of a gene knockdown.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18369814      PMCID: PMC2423205          DOI: 10.1007/978-1-60327-070-0_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

Review 2.  RNAi: nature abhors a double-strand.

Authors:  György Hutvágner; Phillip D Zamore
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

3.  Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells.

Authors:  S Yang; S Tutton; E Pierce; K Yoon
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

4.  RNA silencing: the genome's immune system.

Authors:  Ronald H A Plasterk
Journal:  Science       Date:  2002-05-17       Impact factor: 47.728

5.  Many commonly used siRNAs risk off-target activity.

Authors:  Ola Snøve; Torgeir Holen
Journal:  Biochem Biophys Res Commun       Date:  2004-06-18       Impact factor: 3.575

Review 6.  Mechanisms of antiviral action of interferon.

Authors:  C Baglioni; T W Nilsen
Journal:  Interferon       Date:  1983

7.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

8.  Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.

Authors:  B S Herbert; A C Wright; C M Passons; W E Wright; I U Ali; L Kopelovich; J W Shay
Journal:  J Natl Cancer Inst       Date:  2001-01-03       Impact factor: 13.506

Review 9.  Telomerase in the early detection of cancer.

Authors:  J W Shay; A F Gazdar
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

Review 10.  Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer.

Authors:  Ali Ahmed; Trygve Tollefsbol
Journal:  J Am Geriatr Soc       Date:  2003-01       Impact factor: 5.562

View more
  3 in total

1.  Exposure to dsRNA elicits RNA interference in Brachionus manjavacas (Rotifera).

Authors:  Terry W Snell; Tonya L Shearer; Hilary A Smith
Journal:  Mar Biotechnol (NY)       Date:  2010-05-12       Impact factor: 3.619

Review 2.  Strategies targeting telomerase inhibition.

Authors:  Huaping Chen; Yuanyuan Li; Trygve O Tollefsbol
Journal:  Mol Biotechnol       Date:  2008-10-28       Impact factor: 2.695

Review 3.  Therapeutic Targets in Telomerase and Telomere Biology of Cancers.

Authors:  Rajendra Prasad; Deeksha Pal; Wajid Mohammad
Journal:  Indian J Clin Biochem       Date:  2020-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.